Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposals)
Funding Amounts: $50,000 for one year
Summary: Supports fellows and early career faculty conducting innovative ovarian cancer research while developing research independence.
Key Information: Research must take place at a U.S. institution; non-SGO members need an SGO co-investigator or sponsor.
Description
The Foundation for Women's Cancer (FWC) offers this grant within its 2026–2027 Ovarian Cancer Grants category. It supports promising fellows and early career faculty pursuing innovative ovarian cancer research, providing support during their transition to research independence. Applicants should demonstrate a strong commitment to gynecologic oncology research and explain how the proposed work advances their development as independent investigators.
The research scope includes basic, translational, clinical, and population-based projects relevant to prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Additional consideration is given to DNA damage response, immuno-oncology, and antibody-drug conjugates. Priority goes to innovative projects that can generate preliminary data and catalyze future research and extramural funding.
